nodes	percent_of_prediction	percent_of_DWPC	metapath
Gamma Hydroxybutyric Acid—SLC16A1—Methotrexate—esophageal cancer	0.518	1	CbGbCtD
Gamma Hydroxybutyric Acid—SLC52A2—bronchus—esophageal cancer	0.016	0.109	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—trachea—esophageal cancer	0.0144	0.0981	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—Basigin interactions—ATP1B2—esophageal cancer	0.0128	0.0876	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC52A2—lung—esophageal cancer	0.0104	0.0705	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—epithelium—esophageal cancer	0.00972	0.0661	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—bronchus—esophageal cancer	0.00957	0.0651	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—smooth muscle tissue—esophageal cancer	0.00936	0.0637	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—bronchus—esophageal cancer	0.00913	0.0622	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—trachea—esophageal cancer	0.00859	0.0585	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—Pyruvate metabolism—CRABP1—esophageal cancer	0.00828	0.0568	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—trachea—esophageal cancer	0.0082	0.0558	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—digestive system—esophageal cancer	0.00739	0.0503	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—lymph node—esophageal cancer	0.00708	0.0482	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—Basigin interactions—ATP1B2—esophageal cancer	0.00691	0.0473	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—lung—esophageal cancer	0.00617	0.042	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—epithelium—esophageal cancer	0.0059	0.0402	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—lung—esophageal cancer	0.00589	0.0401	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00518	0.0355	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—esophageal cancer	0.00501	0.0343	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.00474	0.0325	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—digestive system—esophageal cancer	0.00449	0.0306	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—Pyruvate metabolism—CRABP1—esophageal cancer	0.00447	0.0307	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—ATP1B2—esophageal cancer	0.00425	0.0291	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—lymph node—esophageal cancer	0.00422	0.0287	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.0041	0.0281	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—lymph node—esophageal cancer	0.00403	0.0274	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—lung—esophageal cancer	0.00375	0.0255	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.00375	0.0257	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Panic attack—Capecitabine—esophageal cancer	0.00374	0.0197	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—esophageal cancer	0.00271	0.0185	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—lymph node—esophageal cancer	0.00256	0.0175	CbGeAlD
Gamma Hydroxybutyric Acid—Balance disorder—Capecitabine—esophageal cancer	0.00255	0.0134	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00236	0.0161	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Ageusia—Cisplatin—esophageal cancer	0.00233	0.0123	CcSEcCtD
Gamma Hydroxybutyric Acid—Myoclonus—Capecitabine—esophageal cancer	0.00232	0.0122	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—ATP1B2—esophageal cancer	0.0023	0.0157	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Infection—Carboplatin—esophageal cancer	0.00228	0.0121	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00221	0.0152	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Neck stiffness—Methotrexate—esophageal cancer	0.00218	0.0115	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00215	0.0148	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hyperuricaemia—Cisplatin—esophageal cancer	0.00204	0.0108	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Orphan transporters—SLC10A2—esophageal cancer	0.00203	0.0139	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.00202	0.0139	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Neuralgia—Capecitabine—esophageal cancer	0.002	0.0106	CcSEcCtD
Gamma Hydroxybutyric Acid—Nuchal rigidity—Methotrexate—esophageal cancer	0.002	0.0105	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Carboplatin—esophageal cancer	0.00197	0.0104	CcSEcCtD
Gamma Hydroxybutyric Acid—Metrorrhagia—Capecitabine—esophageal cancer	0.00195	0.0103	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—GABA receptor activation—GNG7—esophageal cancer	0.00195	0.0133	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—esophageal cancer	0.00194	0.0133	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Blood uric acid increased—Cisplatin—esophageal cancer	0.00192	0.0102	CcSEcCtD
Gamma Hydroxybutyric Acid—Hiccups—Cisplatin—esophageal cancer	0.00189	0.00997	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00186	0.0128	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Fluid retention—Cisplatin—esophageal cancer	0.00179	0.00947	CcSEcCtD
Gamma Hydroxybutyric Acid—Memory impairment—Capecitabine—esophageal cancer	0.00177	0.00937	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—CAPZA1—esophageal cancer	0.00174	0.0119	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Ageusia—Capecitabine—esophageal cancer	0.00172	0.00907	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.0017	0.0117	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Musculoskeletal stiffness—Capecitabine—esophageal cancer	0.00155	0.00819	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.00153	0.00808	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypocalcaemia—Capecitabine—esophageal cancer	0.00152	0.00803	CcSEcCtD
Gamma Hydroxybutyric Acid—Nasal congestion—Cisplatin—esophageal cancer	0.00151	0.00795	CcSEcCtD
Gamma Hydroxybutyric Acid—Paralysis—Methotrexate—esophageal cancer	0.00149	0.00788	CcSEcCtD
Gamma Hydroxybutyric Acid—Amnesia—Cisplatin—esophageal cancer	0.00146	0.0077	CcSEcCtD
Gamma Hydroxybutyric Acid—Hiccups—Capecitabine—esophageal cancer	0.00139	0.00735	CcSEcCtD
Gamma Hydroxybutyric Acid—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.00139	0.00735	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood pressure increased—Capecitabine—esophageal cancer	0.00139	0.00735	CcSEcCtD
Gamma Hydroxybutyric Acid—Stupor—Methotrexate—esophageal cancer	0.00139	0.00733	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary incontinence—Capecitabine—esophageal cancer	0.00134	0.0071	CcSEcCtD
Gamma Hydroxybutyric Acid—Depressed level of consciousness—Capecitabine—esophageal cancer	0.00134	0.0071	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00134	0.0092	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Ion channel transport—ATP1B2—esophageal cancer	0.00134	0.00916	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Fluid retention—Capecitabine—esophageal cancer	0.00132	0.00698	CcSEcCtD
Gamma Hydroxybutyric Acid—Irritability—Cisplatin—esophageal cancer	0.00131	0.00691	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood creatinine increased—Cisplatin—esophageal cancer	0.00128	0.00678	CcSEcCtD
Gamma Hydroxybutyric Acid—Dehydration—Cisplatin—esophageal cancer	0.00128	0.00673	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.00126	0.00865	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Ecchymosis—Capecitabine—esophageal cancer	0.00126	0.00665	CcSEcCtD
Gamma Hydroxybutyric Acid—Mouth ulceration—Capecitabine—esophageal cancer	0.00126	0.00665	CcSEcCtD
Gamma Hydroxybutyric Acid—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00124	0.00652	CcSEcCtD
Gamma Hydroxybutyric Acid—Nasopharyngitis—Cisplatin—esophageal cancer	0.00123	0.00647	CcSEcCtD
Gamma Hydroxybutyric Acid—Apnoea—Methotrexate—esophageal cancer	0.00122	0.00646	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disability—Capecitabine—esophageal cancer	0.00121	0.00638	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.0012	0.0082	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Sleep disorder—Capecitabine—esophageal cancer	0.00117	0.00616	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00116	0.00613	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Ion channel transport—ATP4A—esophageal cancer	0.00116	0.00794	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00116	0.0061	CcSEcCtD
Gamma Hydroxybutyric Acid—Sweating increased—Cisplatin—esophageal cancer	0.00115	0.00609	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ATP1B2—esophageal cancer	0.00115	0.0079	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Bone disorder—Methotrexate—esophageal cancer	0.00115	0.00606	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00114	0.00783	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.00114	0.00602	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperuricaemia—Methotrexate—esophageal cancer	0.00112	0.0059	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00109	0.0075	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00109	0.0075	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Libido decreased—Capecitabine—esophageal cancer	0.00109	0.00575	CcSEcCtD
Gamma Hydroxybutyric Acid—Amnesia—Capecitabine—esophageal cancer	0.00108	0.00568	CcSEcCtD
Gamma Hydroxybutyric Acid—Thirst—Capecitabine—esophageal cancer	0.00106	0.00561	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.00106	0.00728	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Blood uric acid increased—Methotrexate—esophageal cancer	0.00106	0.00557	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—esophageal cancer	0.00105	0.00719	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—DOCK2—esophageal cancer	0.00104	0.00715	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Arthritis—Capecitabine—esophageal cancer	0.00104	0.00549	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Cisplatin—esophageal cancer	0.00103	0.00544	CcSEcCtD
Gamma Hydroxybutyric Acid—Cystitis noninfective—Methotrexate—esophageal cancer	0.00101	0.00535	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain in extremity—Capecitabine—esophageal cancer	0.00101	0.00534	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.00101	0.00689	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.001	0.00529	CcSEcCtD
Gamma Hydroxybutyric Acid—Cystitis—Methotrexate—esophageal cancer	0.001	0.00528	CcSEcCtD
Gamma Hydroxybutyric Acid—Depressed level of consciousness—Methotrexate—esophageal cancer	0.001	0.00528	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000998	0.00684	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Irritability—Capecitabine—esophageal cancer	0.000965	0.00509	CcSEcCtD
Gamma Hydroxybutyric Acid—Ataxia—Capecitabine—esophageal cancer	0.000951	0.00502	CcSEcCtD
Gamma Hydroxybutyric Acid—Coma—Methotrexate—esophageal cancer	0.000947	0.005	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood creatinine increased—Capecitabine—esophageal cancer	0.000947	0.005	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000946	0.00648	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dehydration—Capecitabine—esophageal cancer	0.00094	0.00496	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CAPZA1—esophageal cancer	0.00094	0.00644	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Mouth ulceration—Methotrexate—esophageal cancer	0.000937	0.00495	CcSEcCtD
Gamma Hydroxybutyric Acid—Bladder pain—Methotrexate—esophageal cancer	0.000937	0.00495	CcSEcCtD
Gamma Hydroxybutyric Acid—Ecchymosis—Methotrexate—esophageal cancer	0.000937	0.00495	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Cisplatin—esophageal cancer	0.000937	0.00495	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Cisplatin—esophageal cancer	0.000932	0.00492	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Cisplatin—esophageal cancer	0.00093	0.00491	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain upper—Capecitabine—esophageal cancer	0.000923	0.00487	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00092	0.0063	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00091	0.00481	CcSEcCtD
Gamma Hydroxybutyric Acid—Nasopharyngitis—Capecitabine—esophageal cancer	0.000904	0.00477	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000903	0.00619	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PFN1—esophageal cancer	0.0009	0.00617	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG7—esophageal cancer	0.000895	0.00614	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000892	0.00471	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscular weakness—Capecitabine—esophageal cancer	0.000892	0.00471	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Cisplatin—esophageal cancer	0.000887	0.00468	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Cisplatin—esophageal cancer	0.000885	0.00467	CcSEcCtD
Gamma Hydroxybutyric Acid—Lymphadenopathy—Methotrexate—esophageal cancer	0.000882	0.00466	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Cisplatin—esophageal cancer	0.000881	0.00465	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal distension—Capecitabine—esophageal cancer	0.00088	0.00464	CcSEcCtD
Gamma Hydroxybutyric Acid—Influenza—Capecitabine—esophageal cancer	0.000874	0.00461	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000866	0.00593	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000866	0.00593	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Immune system disorder—Cisplatin—esophageal cancer	0.000857	0.00452	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Cisplatin—esophageal cancer	0.000855	0.00451	CcSEcCtD
Gamma Hydroxybutyric Acid—Sweating increased—Capecitabine—esophageal cancer	0.000851	0.00449	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Cisplatin—esophageal cancer	0.000838	0.00443	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00083	0.00569	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Malnutrition—Cisplatin—esophageal cancer	0.000826	0.00436	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight increased—Capecitabine—esophageal cancer	0.000795	0.0042	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Cisplatin—esophageal cancer	0.000794	0.00419	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight decreased—Capecitabine—esophageal cancer	0.000791	0.00417	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperglycaemia—Capecitabine—esophageal cancer	0.000788	0.00416	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Capecitabine—esophageal cancer	0.000779	0.00411	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Capecitabine—esophageal cancer	0.000779	0.00411	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Cisplatin—esophageal cancer	0.000778	0.00411	CcSEcCtD
Gamma Hydroxybutyric Acid—Depression—Capecitabine—esophageal cancer	0.000777	0.0041	CcSEcCtD
Gamma Hydroxybutyric Acid—Tremor—Cisplatin—esophageal cancer	0.000774	0.00408	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Cisplatin—esophageal cancer	0.000763	0.00403	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Capecitabine—esophageal cancer	0.000759	0.00401	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000753	0.00516	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Haematuria—Capecitabine—esophageal cancer	0.000743	0.00392	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Capecitabine—esophageal cancer	0.000735	0.00388	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—CFL1—esophageal cancer	0.000729	0.005	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Irritability—Methotrexate—esophageal cancer	0.000718	0.00379	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Cisplatin—esophageal cancer	0.000716	0.00378	CcSEcCtD
Gamma Hydroxybutyric Acid—Ataxia—Methotrexate—esophageal cancer	0.000708	0.00374	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Cisplatin—esophageal cancer	0.000703	0.00371	CcSEcCtD
Gamma Hydroxybutyric Acid—Rhinitis—Capecitabine—esophageal cancer	0.000701	0.0037	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Cisplatin—esophageal cancer	0.000701	0.0037	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000698	0.00369	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Capecitabine—esophageal cancer	0.000696	0.00367	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Capecitabine—esophageal cancer	0.000694	0.00366	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Capecitabine—esophageal cancer	0.000691	0.00365	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Capecitabine—esophageal cancer	0.000689	0.00364	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—GNG7—esophageal cancer	0.000688	0.00471	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Capecitabine—esophageal cancer	0.000687	0.00363	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Capecitabine—esophageal cancer	0.000686	0.00362	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Cisplatin—esophageal cancer	0.000674	0.00356	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.000673	0.00461	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Infection—Cisplatin—esophageal cancer	0.00067	0.00353	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Cisplatin—esophageal cancer	0.000661	0.00349	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000656	0.00449	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Skin disorder—Cisplatin—esophageal cancer	0.000655	0.00346	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Capecitabine—esophageal cancer	0.000654	0.00345	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Capecitabine—esophageal cancer	0.000652	0.00344	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Cisplatin—esophageal cancer	0.000652	0.00344	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Capecitabine—esophageal cancer	0.000649	0.00343	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Cisplatin—esophageal cancer	0.000643	0.00339	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Capecitabine—esophageal cancer	0.000635	0.00335	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Capecitabine—esophageal cancer	0.000632	0.00333	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000631	0.00432	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Capecitabine—esophageal cancer	0.00063	0.00333	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Capecitabine—esophageal cancer	0.000628	0.00331	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ATP1B2—esophageal cancer	0.000623	0.00427	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Alopecia—Capecitabine—esophageal cancer	0.000618	0.00326	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000614	0.00324	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Capecitabine—esophageal cancer	0.000613	0.00323	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Capecitabine—esophageal cancer	0.000609	0.00321	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Cisplatin—esophageal cancer	0.000605	0.00319	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Cisplatin—esophageal cancer	0.000601	0.00317	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Capecitabine—esophageal cancer	0.000596	0.00315	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000595	0.00408	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Back pain—Capecitabine—esophageal cancer	0.000589	0.00311	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Cisplatin—esophageal cancer	0.000586	0.00309	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Capecitabine—esophageal cancer	0.000585	0.00309	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SLC52A3—esophageal cancer	0.000585	0.00401	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—BLVRB—esophageal cancer	0.000585	0.00401	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000582	0.00307	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Methotrexate—esophageal cancer	0.00058	0.00306	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Methotrexate—esophageal cancer	0.00058	0.00306	CcSEcCtD
Gamma Hydroxybutyric Acid—Depression—Methotrexate—esophageal cancer	0.000578	0.00305	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Cisplatin—esophageal cancer	0.000576	0.00304	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Capecitabine—esophageal cancer	0.000574	0.00303	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000573	0.00393	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Tremor—Capecitabine—esophageal cancer	0.00057	0.00301	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Methotrexate—esophageal cancer	0.000565	0.00298	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—DOCK2—esophageal cancer	0.000563	0.00386	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Anaemia—Capecitabine—esophageal cancer	0.000563	0.00297	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—HSPA5—esophageal cancer	0.000561	0.00384	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Feeling abnormal—Cisplatin—esophageal cancer	0.000556	0.00293	CcSEcCtD
Gamma Hydroxybutyric Acid—Haematuria—Methotrexate—esophageal cancer	0.000553	0.00292	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Methotrexate—esophageal cancer	0.000547	0.00289	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Capecitabine—esophageal cancer	0.000547	0.00289	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Capecitabine—esophageal cancer	0.000546	0.00288	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000539	0.00369	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Palpitations—Capecitabine—esophageal cancer	0.000538	0.00284	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Capecitabine—esophageal cancer	0.000535	0.00282	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Capecitabine—esophageal cancer	0.000526	0.00277	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Capecitabine—esophageal cancer	0.000518	0.00274	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Capecitabine—esophageal cancer	0.000518	0.00274	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Capecitabine—esophageal cancer	0.000518	0.00274	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Methotrexate—esophageal cancer	0.000517	0.00273	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Capecitabine—esophageal cancer	0.000517	0.00273	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—GNG7—esophageal cancer	0.000516	0.00353	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000515	0.00272	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Methotrexate—esophageal cancer	0.000514	0.00271	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000511	0.0035	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Urethral disorder—Methotrexate—esophageal cancer	0.00051	0.00269	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Capecitabine—esophageal cancer	0.000507	0.00268	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Capecitabine—esophageal cancer	0.000501	0.00264	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—PIK3CA—esophageal cancer	0.000499	0.00342	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SLC10A2—esophageal cancer	0.000497	0.00341	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CA1—esophageal cancer	0.000497	0.00341	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Oedema—Capecitabine—esophageal cancer	0.000497	0.00262	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Cisplatin—esophageal cancer	0.000497	0.00262	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000495	0.00339	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Infection—Capecitabine—esophageal cancer	0.000494	0.00261	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Capecitabine—esophageal cancer	0.000489	0.00258	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000488	0.00334	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nervous system disorder—Capecitabine—esophageal cancer	0.000487	0.00257	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Methotrexate—esophageal cancer	0.000487	0.00257	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PFN1—esophageal cancer	0.000486	0.00333	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Tinnitus—Methotrexate—esophageal cancer	0.000485	0.00256	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Cisplatin—esophageal cancer	0.000484	0.00255	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—ALDH2—esophageal cancer	0.000483	0.00331	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Cardiac disorder—Methotrexate—esophageal cancer	0.000483	0.00255	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Capecitabine—esophageal cancer	0.000483	0.00255	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Capecitabine—esophageal cancer	0.00048	0.00254	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Capecitabine—esophageal cancer	0.000474	0.0025	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Methotrexate—esophageal cancer	0.000472	0.00249	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Methotrexate—esophageal cancer	0.00047	0.00248	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Methotrexate—esophageal cancer	0.000469	0.00248	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000467	0.0032	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000467	0.0032	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Chills—Methotrexate—esophageal cancer	0.000467	0.00247	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000465	0.00319	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Cisplatin—esophageal cancer	0.000461	0.00243	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Methotrexate—esophageal cancer	0.00046	0.00243	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000459	0.00314	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Mental disorder—Methotrexate—esophageal cancer	0.000456	0.00241	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CA2—esophageal cancer	0.000455	0.00312	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Malnutrition—Methotrexate—esophageal cancer	0.000453	0.00239	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000453	0.00239	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Capecitabine—esophageal cancer	0.000449	0.00237	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Capecitabine—esophageal cancer	0.000446	0.00236	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Orphan transporters—CREBBP—esophageal cancer	0.000444	0.00304	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dysgeusia—Methotrexate—esophageal cancer	0.000444	0.00234	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Capecitabine—esophageal cancer	0.000443	0.00234	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000441	0.00302	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.00044	0.00302	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Back pain—Methotrexate—esophageal cancer	0.000438	0.00231	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Capecitabine—esophageal cancer	0.000437	0.00231	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Capecitabine—esophageal cancer	0.000432	0.00228	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000429	0.00226	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Cisplatin—esophageal cancer	0.000429	0.00226	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Capecitabine—esophageal cancer	0.000428	0.00226	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Methotrexate—esophageal cancer	0.000427	0.00225	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Cisplatin—esophageal cancer	0.000425	0.00224	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Capecitabine—esophageal cancer	0.000425	0.00224	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Capecitabine—esophageal cancer	0.000425	0.00224	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Cisplatin—esophageal cancer	0.000425	0.00224	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PLCE1—esophageal cancer	0.000423	0.0029	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ADH7—esophageal cancer	0.000423	0.0029	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000421	0.00288	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Anaemia—Methotrexate—esophageal cancer	0.000419	0.00221	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ABL1—esophageal cancer	0.000415	0.00285	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Feeling abnormal—Capecitabine—esophageal cancer	0.00041	0.00216	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Methotrexate—esophageal cancer	0.000407	0.00215	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000406	0.00214	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000403	0.00276	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000403	0.00276	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Cisplatin—esophageal cancer	0.0004	0.00211	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Capecitabine—esophageal cancer	0.000395	0.00208	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CFL1—esophageal cancer	0.000394	0.0027	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Abdominal pain—Capecitabine—esophageal cancer	0.000393	0.00207	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Methotrexate—esophageal cancer	0.000393	0.00207	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Methotrexate—esophageal cancer	0.000386	0.00204	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Methotrexate—esophageal cancer	0.000386	0.00204	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Methotrexate—esophageal cancer	0.000386	0.00204	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000383	0.00202	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Methotrexate—esophageal cancer	0.000373	0.00197	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—GNG7—esophageal cancer	0.000371	0.00254	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ADH1B—esophageal cancer	0.000371	0.00254	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Infection—Methotrexate—esophageal cancer	0.000368	0.00194	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Capecitabine—esophageal cancer	0.000366	0.00193	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Methotrexate—esophageal cancer	0.000363	0.00191	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000363	0.00249	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Skin disorder—Methotrexate—esophageal cancer	0.000359	0.0019	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Methotrexate—esophageal cancer	0.000358	0.00189	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Capecitabine—esophageal cancer	0.000357	0.00188	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—TYMP—esophageal cancer	0.000354	0.00243	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000354	0.00243	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Anorexia—Methotrexate—esophageal cancer	0.000353	0.00186	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000348	0.00239	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP26A1—esophageal cancer	0.000345	0.00236	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Capecitabine—esophageal cancer	0.00034	0.00179	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000337	0.00178	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ALOX15—esophageal cancer	0.000336	0.0023	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Insomnia—Methotrexate—esophageal cancer	0.000335	0.00177	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Methotrexate—esophageal cancer	0.000332	0.00175	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Methotrexate—esophageal cancer	0.00033	0.00174	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Methotrexate—esophageal cancer	0.000329	0.00174	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Capecitabine—esophageal cancer	0.000329	0.00173	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Methotrexate—esophageal cancer	0.000326	0.00172	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Methotrexate—esophageal cancer	0.000322	0.0017	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000321	0.0022	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTO1—esophageal cancer	0.00032	0.0022	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—TPI1—esophageal cancer	0.00032	0.0022	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000319	0.00169	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Methotrexate—esophageal cancer	0.000319	0.00168	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Methotrexate—esophageal cancer	0.000316	0.00167	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Capecitabine—esophageal cancer	0.000316	0.00167	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC52A3—esophageal cancer	0.000316	0.00216	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—BLVRB—esophageal cancer	0.000316	0.00216	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Rash—Capecitabine—esophageal cancer	0.000313	0.00165	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Capecitabine—esophageal cancer	0.000313	0.00165	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Capecitabine—esophageal cancer	0.000311	0.00164	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ALDOB—esophageal cancer	0.000307	0.00211	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000306	0.00209	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Feeling abnormal—Methotrexate—esophageal cancer	0.000305	0.00161	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—HSPA5—esophageal cancer	0.000303	0.00207	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000303	0.0016	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—NOS2—esophageal cancer	0.000299	0.00205	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GAPDH—esophageal cancer	0.000296	0.00203	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Capecitabine—esophageal cancer	0.000295	0.00156	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000294	0.00202	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Urticaria—Methotrexate—esophageal cancer	0.000294	0.00155	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CRABP1—esophageal cancer	0.000293	0.00201	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Abdominal pain—Methotrexate—esophageal cancer	0.000292	0.00154	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GNG7—esophageal cancer	0.000279	0.00191	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000277	0.0019	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypersensitivity—Methotrexate—esophageal cancer	0.000273	0.00144	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—esophageal cancer	0.00027	0.00185	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—CREBBP—esophageal cancer	0.000269	0.00184	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CA1—esophageal cancer	0.000269	0.00184	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC10A2—esophageal cancer	0.000269	0.00184	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Methotrexate—esophageal cancer	0.000265	0.0014	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ALDH2—esophageal cancer	0.000261	0.00179	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Methotrexate—esophageal cancer	0.000253	0.00134	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTT1—esophageal cancer	0.000248	0.0017	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CA2—esophageal cancer	0.000246	0.00168	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP2A6—esophageal cancer	0.000246	0.00168	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dizziness—Methotrexate—esophageal cancer	0.000245	0.00129	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—NOS3—esophageal cancer	0.000241	0.00165	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Methotrexate—esophageal cancer	0.000235	0.00124	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Methotrexate—esophageal cancer	0.000233	0.00123	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Methotrexate—esophageal cancer	0.000233	0.00123	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PTGS1—esophageal cancer	0.000233	0.0016	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ENO1—esophageal cancer	0.000233	0.0016	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000233	0.00159	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Methotrexate—esophageal cancer	0.000232	0.00122	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PSME1—esophageal cancer	0.000229	0.00157	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PSME2—esophageal cancer	0.000229	0.00157	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PLCE1—esophageal cancer	0.000228	0.00156	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ADH7—esophageal cancer	0.000228	0.00156	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ABL1—esophageal cancer	0.000224	0.00154	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Methotrexate—esophageal cancer	0.00022	0.00116	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ADH1B—esophageal cancer	0.0002	0.00137	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP1B1—esophageal cancer	0.000198	0.00136	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000196	0.00134	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—TYMP—esophageal cancer	0.000191	0.00131	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000188	0.00129	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP19A1—esophageal cancer	0.000186	0.00128	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP26A1—esophageal cancer	0.000186	0.00128	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—EP300—esophageal cancer	0.000183	0.00125	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ALOX15—esophageal cancer	0.000181	0.00124	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTO1—esophageal cancer	0.000173	0.00119	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—TPI1—esophageal cancer	0.000173	0.00119	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HMOX1—esophageal cancer	0.00017	0.00116	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000169	0.00116	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ALDOB—esophageal cancer	0.000166	0.00114	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ABCB1—esophageal cancer	0.000163	0.00112	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000162	0.00111	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—NOS2—esophageal cancer	0.000162	0.00111	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GAPDH—esophageal cancer	0.00016	0.00109	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CRABP1—esophageal cancer	0.000158	0.00108	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GNG7—esophageal cancer	0.000151	0.00103	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CREBBP—esophageal cancer	0.000145	0.000994	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ALDH2—esophageal cancer	0.000141	0.000967	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CA—esophageal cancer	0.000135	0.000928	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTT1—esophageal cancer	0.000134	0.000919	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP2A6—esophageal cancer	0.000133	0.000909	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—TP53—esophageal cancer	0.000131	0.000898	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—NOS3—esophageal cancer	0.00013	0.00089	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PTGS1—esophageal cancer	0.000126	0.000862	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ENO1—esophageal cancer	0.000126	0.000862	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000126	0.000861	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PSME2—esophageal cancer	0.000124	0.000849	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PSME1—esophageal cancer	0.000124	0.000849	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CREBBP—esophageal cancer	0.000109	0.000747	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000108	0.000743	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP1B1—esophageal cancer	0.000107	0.000733	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP19A1—esophageal cancer	0.000101	0.000689	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—EP300—esophageal cancer	9.88e-05	0.000677	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NOS3—esophageal cancer	9.76e-05	0.000669	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HMOX1—esophageal cancer	9.17e-05	0.000629	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PTGS2—esophageal cancer	8.92e-05	0.000611	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ABCB1—esophageal cancer	8.8e-05	0.000603	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—EP300—esophageal cancer	7.42e-05	0.000509	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CA—esophageal cancer	7.31e-05	0.000501	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—TP53—esophageal cancer	7.07e-05	0.000485	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CREBBP—esophageal cancer	5.88e-05	0.000403	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CA—esophageal cancer	5.49e-05	0.000376	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NOS3—esophageal cancer	5.27e-05	0.000361	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PTGS2—esophageal cancer	4.82e-05	0.00033	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—EP300—esophageal cancer	4.01e-05	0.000275	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CA—esophageal cancer	2.96e-05	0.000203	CbGpPWpGaD
